The PE Ratio as of October 2024 (TTM) for Haleon plc (HLN) is 31.61

According to Haleon plc’s latest financial reports and current stock price. The company's current PE Ratio is 31.61. This represents a change of -104.61% compared to the average of -685.97 of the last 4 quarters.

Haleon plc (HLN) Historical PE Ratio (quarterly & annually)

How has HLN PE Ratio performed in the past?

The mean historical PE Ratio of Haleon plc over the last ten years is 55.12. The current 31.61 PE Ratio has changed 5.64% with respect to the historical average. Over the past ten years (40 quarters), HLN's PE Ratio was at its highest in in the December 2022 quarter at 77.11. The PE Ratio was at its lowest in in the December 2023 quarter at -2833.30.

Haleon plc (HLN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Haleon plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Haleon plc (HLN) Average PE Ratio

How has HLN PE Ratio performed in the past?

The current PE Ratio of Haleon plc (HLN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Haleon plc (HLN) PE Ratio vs. Peers

How is HLN’s PE Ratio compared to its peers?

Haleon plc’s PE Ratio is greater than Teva Pharmaceutical Industries Limited (-44.34), greater than Bausch Health Companies Inc. (-81.87), less than Zoetis Inc. (35.51), greater than Takeda Pharmaceutical Company Limited (22.31), greater than Dr. Reddy's Laboratories Limited (18.71), greater than Emergent BioSolutions Inc. (-0.86), greater than HUTCHMED (China) Limited (-388.32), greater than Viatris Inc. (-21.91), less than PetIQ, Inc. (69.35), less than Neurocrine Biosciences, Inc. (32.57), greater than Elanco Animal Health Incorporated (-5.03), greater than Catalent, Inc. (-10.68), greater than Lantheus Holdings, Inc. (17.70), greater than SIGA Technologies, Inc. (6.00), greater than Indivior PLC (-584.17), greater than Esperion Therapeutics, Inc. (-4.08),

Build a custom stock screener for Haleon plc (HLN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Haleon plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Haleon plc (HLN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Haleon plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.